A. Research Articles (2015~)   *Corresponding author  #Co-first author  

Yang AC, Hong CJ, Liou YJ, Huang KL, Huang CC, Liu ME, Lo MT, Huang NE, Peng CK, Lin CP, Tsai SJ. Decreased resting-state brain activity complexity in schizophrenia characterized by both increased regularity and randomness. Hum Brain Mapp.2015 Jun;36(6):2174-86.

Chih-Ya Cheng, Jaw-Ching Wu, Jin-Wu Tsai, Fang-Shin Nian, Pei-Chun Wu, Lung-Sen Kao, Ming-Ji Fann, Shih-Jen Tsai, Ying-Jay Liou, Chin-Yin Tai, Chen-Jee Hong*. ENU mutagenesis identifies mice modeling Warburg Micro syndrome with sensory axon degeneration caused by a deletion in Rab18. Experimental Neurology 267 (2015) 143–151.

Wu YY, Hsu JL, Wang HC, Wu SJ, Hong CJ, Cheng IH. Alterations of the Neuroinflammatory Markers IL-6 and TRAIL in Alzheimer's Disease. Dement Geriatr Cogn Dis Extra. 2015 Nov 24;5(3):424-34.

Li CT, Tu PC, Hsieh JC, Lee HC, Bai YM, Tsai CF, Wang SJ, Hsu JW, Huang KL, Hong CJ, Su TP. Functional dysconnection in the prefrontal-amygdala circuitry in unaffected siblings of patients with bipolar I disorder. Bipolar Disord. 2015 Sep;17(6):626-35.

Sun GG, Shih JH, Chiou SH, Hong CJ, Lu SW, Pao LH. Chinese herbal medicines promote hippocampal neuroproliferation, reduce stress hormone levels, inhibit apoptosis, and improve behavior in chronically stressed mice. J Ethnopharmacol. 2016 Dec 4;193:159-168.

Li CT, Chen MH, Lin WC, Hong CJ, Yang BH, Liu RS, Tu PC, Su TP. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study. Hum Brain Mapp. 2016 Mar;37(3):1080-90.

Biernacka JM, Sangkuhl K, Jenkins G, Whaley RM, Barman P, Batzler A, Altman RB, Arolt V, Brockmöller J, Chen CH, Domschke K, Hall-Flavin DK, Hong CJ, Illi A, Ji Y, Kampman O, Kinoshita T, Leinonen E, Liou YJ, Mushiroda T, Nonen S, Skime MK, Wang L, Baune BT, Kato M, Liu YL, Praphanphoj V, Stingl JC, Tsai SJ, Kubo M, Klein TE, Weinshilboum R. The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response. Transl Psychiatry. 2016 Nov 1;6(11):e937.

Su TP, Chen MH, Li CT, Lin WC, Hong CJ, Gueorguieva R, Tu PC, Bai YM, Cheng CM, Krystal JH. Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression. Neuropsychopharmacology. 2017 Dec;42(13):2482-2492.

Amare AT, Schubert KO, Tekola-Ayele F, Hsu YH, Sangkuhl K, Jenkins G, Whaley RM, Barman P, Batzler A, Altman RB, Arolt V, Brockmöller J, Chen CH, Domschke K, Hall-Flavin DK, Hong CJ, Illi A, Ji Y, Kampman O, Kinoshita T, Leinonen E, Liou YJ, Mushiroda T, Nonen S, Skime MK, Wang L, Kato M, Liu YL, Praphanphoj V, Stingl JC, Bobo WV, Tsai SJ, Kubo M, Klein TE, Weinshilboum RM, Biernacka JM, Baune BT. Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. Front Psychiatry. 2018 Mar 6;9:65.

Chen MH, Li CT, Lin WC, Hong CJ, Tu PC, Bai YM, Cheng CM, Su TP. Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study. J Affect Disord. 2018 Jan 1;225:709-714.

Chen MH, Li CT, Lin WC, Hong CJ, Tu PC, Bai YM, Cheng CM, Su TP. Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion. J Affect Disord. 2018 Dec 1;241:1-7.

Chen MH, Li CT, Lin WC, Hong CJ, Tu PC, Bai YM, Cheng CM, Su TP. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study. Psychiatry Res. 2018 Nov;269:207-211.

Nian FS, Li LL, Cheng CY, Wu PC, Lin YT, Tang CY, Ren BS, Tai CY, Fann MJ, Kao LS, Hong CJ, Tsai JW. Rab18 Collaborates with Rab7 to Modulate Lysosomal and Autophagy Activities in the Nervous System: an Overlapping Mechanism for Warburg Micro Syndrome and Charcot-Marie-Tooth Neuropathy Type 2B. Mol Neurobiol. 2019 Sep;56(9):6095-6105.

Chen MH, Lin WC, Wu HJ, Cheng CM, Li CT, Hong CJ, Tu PC, Bai YM, Tsai SJ, Su TP. Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD). J Affect Disord. 2019 May 15;251:162-169.

Chen MH, Cheng CM, Gueorguieva R, Lin WC, Li CT, Hong CJ, Tu PC, Bai YM, Tsai SJ, Krystal JH, Su TP. Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study. Neuropsychopharmacology. 2019 Nov;44(12):2112-2118.

Su CH, Chuang HC, Hong CJ*. Physical exercise prevents mice from KYN-induced depression-like behavior. Asian J Psychiatr. 2020 Feb;48:101894.

Lin SY, Yang CP, Wang YY, Hsiao CW, Chen WY, Liao SL, Lo YL, Chang YH, Hong CJ, Chen CJ*.  Interleukin-4 Improves Metabolic Abnormalities in Leptin Deficient and High-Fat Diet Mice. Int. J. Mol. Sci. 2020, 21, 4451.

Chen MH, Lin WC, Wu HJ, Bai YM, Li CT, Tsai SJ, Hong CJ, Tu PC, Cheng CM, Su TP. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression. CNS Spectr
. 2020 May 18;1-6.

　

B. Review Articles

  1. 洪成志、廖敏華、王正如、鄭之雅：遺傳性失智症的基因檢測與諮詢。台灣醫界 2011;54(9):10-18.

Updated: 2020/10/19 by Hong CJ